TMBR stock forecast
Our latest prediction for Timber Pharmaceuticals Inc's stock price was made on the Aug. 26, 2021 when the stock price was at 0.94$.
In the short term (2weeks), TMBR's stock price should outperform the market by 1.46%. During that period the price should oscillate between -13.45% and +17.69%.
In the medium term (3months), TMBR's stock price should outperform the market by 37.12%. During that period the price should oscillate between -46.39% and +61.78%.Get email alerts
Create a solid portfolio with TMBR
About Timber Pharmaceuticals Inc
Timber Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan dermatologic diseases. The Company's investigational therapies have proven mechanisms-of-action backed by decades of clinical experience and well-established CMC (chemistry, manufacturing and control) and safety profiles. The Company is initially focused on developing non-systemic treatments for rare dermatologic diseases including congenital ichthyosis (CI), facial angiofibromas (FAs) in tuberous sclerosis complex (TSC), and scleroderma.
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a profit of 1.04$ per share.
The book value per share is 0.16$
Three months stock forecastAug. 26, 2021
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|